About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 7,985 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 7,985 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 501-520 of 7,985 trials

RecruitingA Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical SurgeryTo assess the efficacy and safety of sunvozertinib versus placebo as adjuvant therapy in patients with stage IB-IIIA non-small cell lung cancer (NSCLC) harboring epidermal growth…NCT07182682·Beijing and 48 others

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

TerminatedStudy of PF-07265807 in Participants With Metastatic Solid Tumors.A First-in-Human Pharmacokinetic, Safety, and Tolerability Study of PF-07265807 as Monotherapy and in Combination in Participants with Advanced or Metastatic Solid TumorsNCT04458259·Fayetteville, Arkansas and 32 others

TerminatedMobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab.A study of whether mobile devices can improve the detection of pulmonary AEs (including pneumonitis) in stage III NSCLC patients post-CRT, while on durvalumab.NCT04381494·Long Beach, California and 17 others

CompletedStudy of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Stage IV Lung CancerThe objective is to evaluate the toxicity profile, response rate, and time to progression of Cetuximab administered in combination with either Carboplatin + Gemcitabine in…NCT01004731·Birmingham, Alabama

WithdrawnEvaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung CancerThis is a prospective, randomized, controlled phase II clinical study for evaluating anlotinib combined with concurrent chemoradiotherapy followed by consolidation immunotherapy…NCT05481775·Guangzhou, Guangdong

TerminatedAzacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing SurgeryThis pilot clinical trials studies azacitidine and entinostat in treating patients with newly diagnosed stage IA-IIIIA non-small cell lung undergoing surgery.NCT01886573·Lexington, Kentucky and 2 others

CompletedReal-world Analysis of Workup at Disease Progression and Implementation of Osimertinib for EGFR+ NSCLCTyrosine kinase inhibitors (TKI) have greatly improved prognosis of epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer (NSCLC), with tumor responses in…NCT04105153·Heidelberg

Active not recruitingA Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLCThis is a Phase III, randomised, double-blind, placebo-controlled, multicentre, international study assessing the efficacy and safety of durvalumab (MEDI4736) and domvanalimab…NCT05211895·Chandler, Arizona and 225 others

CompletedPembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain MetastasesThis pilot trial studies the side effects of giving pembrolizumab together with stereotactic radiosurgery to treat patients with melanoma or non-small cell lung cancer that has…NCT02858869·Atlanta, Georgia

UnknownEBUS-guided TBNA for Molecular Diagnostic of Mediastinal Lymph Nodes (LN)The purpose of this study is to perform molecular diagnostic in mediastinal lymph nodes of non-small cell lung cancer patients sampled by endobronchial ultrasound guided finde…NCT00982605·Heidelberg

CompletedAn Observational Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung CancerThis prospective observational study will evaluate the efficacy and safety of Tarceva (erlotinib) in elderly patients with advanced non-small cell lung cancer (NSCLC) after…NCT01535729·Nuremberg

UnknownBioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and DiagnosticsThe goal of the project is to develop and validate the BioForte technology.NCT04136470·Gdansk and 9 others

CompletedA Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)The goal of this clinical trial was to compare the efficacy and safety of anamorelin HCl (the investigational drug) to that of placebo (tablet with no drug) in patients with…NCT03743051·Tucson, Arizona and 71 others

Active not recruitingFc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced CancerThis study is an open-label, Phase 1, multicenter study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamic (PD) profiles of a novel fragment…NCT03860272·Scottsdale, Arizona and 17 others

TerminatedSurgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung CancerRATIONALE: Surgery with or without internal radiation therapy may be an effective treatment for non-small cell lung cancer.NCT01336894·Birmingham, Alabama and 52 others

RecruitingUnderstanding New Cachexia Subtypes Through Observational Epidemiological ResearchThe UNCOVER study is a longitudinal observational cohort focused on patients at high risk for cancer cachexia.NCT07776353·Pleasanton, California

TerminatedA Study to Investigate LYL797 in Adults With Solid TumorsThis study will evaluate the safety and tolerability of LYL797, a ROR1-targeted CAR T-cell therapy, in patients with ROR1+ relapsed or refractory triple negative breast cancer…NCT05274451·Scottsdale, Arizona and 17 others

CompletedDetection of EGFR Mutations in the Blood of Patients With Non-small Cell Lung Cancer: a Feasibility StudyThe overall objective of the study is to assess the feasibility of the use of blood for the detection of EGFR mutations in patients with non-small cell lung cancer…NCT00717002·Singapore

CompletedCombination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00014456·Lebanon, New Hampshire

RecruitingA Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung CancerThe researchers are doing this study to find out whether ivonescimab in combination with datopotamab deruxtecan- (Dato-DXd) or osimertinib are safe and effective treatments in…NCT07535437·Basking Ridge, New Jersey and 6 others

PreviousPage 26 of 400Next